BioWorld-International-2009-04-15
BioXell Shares Plunge on Elocalcitol Miss
BioXell Shares Plunge on Elocalcitol Miss
BioXell SpA suffered a collapse in its share price following news that its vitamin D3 analogue elocalcitol failed to meet the primary endpoint of a Phase IIb trial in overactive bladder (OAB). (BioWorld International)

